Cargando…
Predictors of clinical response to immunotherapy with or without radiotherapy
Success with recent immunotherapies has resulted in previously unattainable response rates, as well as durable responses in diseases with historically poor prognoses. The combination of radiation therapy and immunotherapy has been a recent area of active investigation, with exciting results in a sub...
Autores principales: | Hiniker, Susan M., Maecker, Holden T., Knox, Susan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685037/ https://www.ncbi.nlm.nih.gov/pubmed/26709361 http://dx.doi.org/10.1007/s13566-015-0219-2 |
Ejemplares similares
-
A pilot study of Ipilimumab in patients with stage IV melanoma receiving palliative radiation therapy
por: Knox, Susan, et al.
Publicado: (2014) -
Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up
por: Gutkin, Paulina M, et al.
Publicado: (2018) -
Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab
por: Sodji, Quaovi H, et al.
Publicado: (2020) -
Recent advances in understanding and managing rhabdomyosarcoma
por: Hiniker, Susan M., et al.
Publicado: (2015) -
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
por: Maecker, Holden T
Publicado: (2021)